ODYS

+ Watchlist + Portfolio

Odysight.ai Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $3.63
52-Week Range: $2.60 – $11.30
Market Cap: $56.30M
P/E (TTM): —
EPS (TTM): -1.10
Dividend Yield: —

Advanced Metrics

Price/Book: 3.24
PEG Ratio: —
Return on Equity: -72.81%
Return on Assets: -41.01%
Gross Margin: 34.86%
Operating Margin: -1078.81%
Profit Margin: 0.00%
Current Ratio: 5.82
Debt/Equity: 0.05
Total Debt: $834.00K
Free Cash Flow: $-9.36M
Revenue Growth: 16.00%
Earnings Growth: —
Enterprise Value: $44.29M

ODYS Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$665.00K	$3.03M	$3.96M	$3.02M
Cost of Revenue	$1.63M	$2.52M	$2.81M	$2.14M
Gross Profit	-$966.00K	$509.00K	$1.16M	$871.00K
Research & Development	$4.52M	$6.27M	$7.34M	$10.70M
Selling, General & Admin	$4.05M	$4.82M	$6.30M	$8.29M
Operating Expenses	$8.47M	$11.14M	$13.66M	$19.01M
Operating Income	-$9.44M	-$10.63M	-$12.51M	-$18.14M
EBITDA	-$9.19M	-$10.35M	-$12.38M	-$18.02M
Pretax Income	-$9.47M	-$9.45M	-$11.77M	-$17.04M
Income Tax	$0.00	$0.00	$0.00	—
Net Income	-$9.47M	-$9.45M	-$11.77M	-$17.04M
Diluted EPS	-1.33	-0.98	-1.03	-1.07
Diluted Shares	7.12M	9.67M	11.45M	15.90M

ODYS Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$10.10M	$8.95M	$18.16M	$25.68M
Receivables	$60.00K	$1.37M	$1.51M	$278.00K
Inventory	$630.00K	$504.00K	$203.00K	$50.00K
Current Assets	$14.12M	$19.35M	$20.79M	$27.50M
Total Assets	$16.89M	$22.83M	$23.68M	$28.98M
Current Liabilities	$2.56M	$2.08M	$3.29M	$3.00M
Total Debt	$263.00K	$1.33M	$1.05M	$770.00K
Total Liabilities	$5.11M	$5.02M	$5.43M	$3.55M
Retained Earnings	-$24.76M	-$34.21M	-$45.97M	-$63.01M
Shareholders' Equity	$11.79M	$17.81M	$18.24M	$25.43M
Working Capital	$11.56M	$17.27M	$17.49M	$24.50M

ODYS Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$6.09M	-$10.01M	-$8.22M	-$13.70M
Capital Expenditure	-$118.00K	-$113.00K	-$53.00K	-$56.00K
Free Cash Flow	-$6.21M	-$10.12M	-$8.27M	-$13.76M
Depreciation & Amortisation	$251.00K	$284.00K	$123.00K	$117.00K
Stock-Based Compensation	$1.64M	$1.66M	$2.39M	$3.08M
Investing Cash Flow	$7.88M	-$5.11M	$7.64M	$254.00K
Financing Cash Flow	$0.00	$13.81M	$9.82M	$21.14M
Net Change in Cash	$1.79M	-$1.31M	$9.24M	$7.69M

ODYS Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$2.06M	$362.00K	$149.00K	$439.00K	$82.00K
Cost of Revenue	$1.53M	$229.00K	$126.00K	$262.00K	$61.00K
Gross Profit	$538.00K	$133.00K	$23.00K	$177.00K	$21.00K
Research & Development	$2.49M	$2.36M	$2.48M	$3.38M	$2.56M
Selling, General & Admin	$2.61M	$2.21M	$2.25M	$1.21M	$2.80M
Operating Expenses	$5.10M	$4.57M	$4.73M	$4.61M	$5.36M
Operating Income	-$4.56M	-$4.44M	-$4.71M	-$4.43M	-$5.34M
EBITDA	-$4.53M	-$4.41M	-$4.68M	-$4.40M	-$5.31M
Pretax Income	-$4.26M	-$4.08M	-$4.42M	-$4.28M	-$5.18M
Net Income	-$4.26M	-$4.08M	-$4.42M	-$4.28M	-$5.18M
Diluted EPS	-0.29	-0.25	-0.27	—	-0.32
Diluted Shares	14.57M	16.32M	16.33M	—	16.39M

ODYS Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$36.88M	$32.91M	$29.48M	$25.68M	$21.76M
Receivables	$192.00K	$509.00K	$354.00K	$278.00K	$104.00K
Inventory	$0.00	$0.00	$0.00	$50.00K	$313.00K
Current Assets	$38.09M	$34.88M	$31.34M	$27.50M	$22.63M
Total Assets	$39.84M	$36.56M	$32.91M	$28.98M	$24.64M
Current Liabilities	$3.42M	$3.29M	$3.21M	$3.00M	$2.98M
Total Debt	$911.00K	$919.00K	$844.00K	$770.00K	$663.00K
Total Liabilities	$4.08M	$3.96M	$3.80M	$3.55M	$3.48M
Retained Earnings	-$50.24M	-$54.31M	-$58.73M	-$63.01M	-$68.19M
Shareholders' Equity	$35.77M	$32.60M	$29.11M	$25.43M	$21.16M
Working Capital	$34.67M	$31.59M	$28.13M	$24.50M	$19.65M

ODYS Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$2.23M	-$4.17M	-$3.42M	-$3.88M	-$4.25M
Capital Expenditure	-$27.00K	-$3.00K	-$11.00K	-$15.00K	-$6.00K
Free Cash Flow	-$2.26M	-$4.17M	-$3.43M	-$3.90M	-$4.26M
Depreciation & Amortisation	$27.00K	$31.00K	$30.00K	$29.00K	$27.00K
Stock-Based Compensation	$806.00K	$845.00K	$914.00K	$513.00K	$886.00K
Investing Cash Flow	$283.00K	-$3.00K	-$11.00K	-$15.00K	-$6.00K
Financing Cash Flow	$21.02M	$34.00K	$1.00K	$82.00K	$32.00K
Share Repurchases	—	-$35.00K	-$7.00K	—	—
Net Change in Cash	$19.07M	-$4.14M	-$3.43M	-$3.81M	-$4.23M

Market Snapshot

About

Medical technology company developing AI-powered visual monitoring solutions for healthcare settings. The platform uses computer vision and machine learning to continuously monitor patients, enabling early detection of deterioration and improving patient safety in hospitals and care facilities.